Terms: = Lung cancer AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2
208 results:
1. Curcumin Alone and Combined With PI3K Inhibitors Elicits Positive Effects on Oropharyngeal cancer Cell Lines Regardless of HPV Status.
Lukoceviciute M; Zupancic M; Kostopoulou ON; Holzhauser S; Dalianis T
Anticancer Res; 2024 May; 44(5):1863-1876. PubMed ID: 38677772
[TBL] [Abstract] [Full Text] [Related]
2. Predisposing deleterious variants in the cancer-associated human kinases in the global populations.
Khan SA; Anwar M; Gohar A; Roosan MR; Hoessli DC; Khatoon A; Shakeel M
PLoS One; 2024; 19(4):e0298747. PubMed ID: 38635549
[TBL] [Abstract] [Full Text] [Related]
3. Atypical Histopathological Aspects of Common Types of lung cancer-Our Experience and Literature Review.
Marghescu AȘ; Leonte DG; Radu AD; Măgheran ED; Tudor AV; Teleagă C; Țigău M; Georgescu L; Costache M
Medicina (Kaunas); 2024 Jan; 60(1):. PubMed ID: 38256374
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic Utility of Next-Generation Sequencing in Circulating Free DNA and a Comparison With Matched Tissue in Gallbladder Carcinoma.
Mishra S; Srivastava P; Pandey A; Shukla S; Agarwal A; Husain N
Lab Invest; 2024 Feb; 104(2):100301. PubMed ID: 38092180
[TBL] [Abstract] [Full Text] [Related]
5. Non-Small Cell lung Carcinoma With Clear Cell Features and fgfr3::TACC3 Gene Rearrangement : Clinicopathologic and Next Generation Sequencing Study of 7 Cases.
Suster D; Mackinnon AC; Ronen N; Mejbel HA; Harada S; Suster S
Am J Surg Pathol; 2024 Mar; 48(3):284-291. PubMed ID: 38084010
[TBL] [Abstract] [Full Text] [Related]
6. Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lung.
Alidousty C; Becker A; Binot E; Hillmer AM; Merkelbach-Bruse S; Budde B; Bäßmann I; Rappl G; Wolf J; Eich ML; Noh KW; Buettner R; Schultheis AM
Gene; 2024 Feb; 895():148018. PubMed ID: 37981082
[TBL] [Abstract] [Full Text] [Related]
7. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
8. Chronic stress induces pulmonary epithelial cells to produce acetylcholine that remodels lung pre-metastatic niche of breast cancer by enhancing NETosis.
Pan J; Zhang L; Wang X; Li L; Yang C; Wang Z; Su K; Hu X; Zhang Y; Ren G; Jiang J; Li P; Huang J
J Exp Clin Cancer Res; 2023 Sep; 42(1):255. PubMed ID: 37773152
[TBL] [Abstract] [Full Text] [Related]
9. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
Diks J; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA; Medeiros LJ; Tang G; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2024 Jan; 132(1):41-49. PubMed ID: 37747438
[TBL] [Abstract] [Full Text] [Related]
10. Detection of Nine Oncogenes Amplification in lung and Colorectal cancer Formalin-Fixed Paraffin-Embedded Tissue Samples using Combined Next-Generation Sequencing-Based Script and Digital Droplet Polymerase Chain Reaction.
Bontoux C; Guyard A; Lupo A; Diallo K; Rebah K; Hercent A; Guenzi E; Cros J; Lamoril J; Leroy K; Theou-Anton N
Cancer Control; 2023; 30():10732748231167257. PubMed ID: 37386758
[TBL] [Abstract] [Full Text] [Related]
11. Resistance to KRAS G12C Inhibition in Non-small Cell lung cancer.
Di Federico A; Ricciotti I; Favorito V; Michelina SV; Scaparone P; Metro G; De Giglio A; Pecci F; Lamberti G; Ambrogio C; Ricciuti B
Curr Oncol Rep; 2023 Sep; 25(9):1017-1029. PubMed ID: 37378881
[TBL] [Abstract] [Full Text] [Related]
12. Erdafitinib in the Treatment of Metastatic Urothelial Carcinoma.
Castro-Alonso FJ; Beas-Lozano E; Remolina-Bonilla YA; Flaig TW; Bourlon MT
Oncology (Williston Park); 2023 Jun; 37(6):256-261. PubMed ID: 37343207
[TBL] [Abstract] [Full Text] [Related]
13. Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors.
Kovács SA; Fekete JT; Győrffy B
Acta Pharmacol Sin; 2023 Sep; 44(9):1879-1889. PubMed ID: 37055532
[TBL] [Abstract] [Full Text] [Related]
14. PRMT5/fgfr3/AKT Signaling Axis Facilitates lung cancer Cell Metastasis.
Zheng Y; Lu J; Hu X; Hu X; Gao X; Zhou J
Technol Cancer Res Treat; 2023; 22():15330338231161139. PubMed ID: 36927233
[No Abstract] [Full Text] [Related]
15. The 27-gene IO score is associated with efficacy of PD-1/L1 inhibitors independent of FGFR expression in a real-world metastatic urothelial carcinoma cohort.
Nielsen TJ; Varga MG; Cronister CT; Ring BZ; Seitz RS; Ross DT; Schweitzer BL; McGregor K
Cancer Immunol Immunother; 2023 Jul; 72(7):2075-2086. PubMed ID: 36806983
[TBL] [Abstract] [Full Text] [Related]
16. Tumor and Stromal Cell Targeting with Nintedanib and Alpelisib Overcomes Intrinsic Bladder cancer Resistance.
Marqués M; Corral S; Sánchez-Díaz M; Del Pozo N; Martínez de Villarreal J; Schweifer N; Zagorac I; Hilberg F; Real FX
Mol Cancer Ther; 2023 May; 22(5):616-629. PubMed ID: 36805958
[TBL] [Abstract] [Full Text] [Related]
17. Oncogenic driver fgfr3-TACC3 requires five coiled-coil heptads for activation and disulfide bond formation for stability.
Wang CG; Peiris MN; Meyer AN; Nelson KN; Donoghue DJ
Oncotarget; 2023 Feb; 14():133-145. PubMed ID: 36780330
[TBL] [Abstract] [Full Text] [Related]
18. lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases.
Demleitner M; Erlenbach-Wünsch K; Coras R; Erber R; Polifka I; Eyüpoğlu I; Fuchs F; Hartmann A; Agaimy A
Ann Diagn Pathol; 2023 Apr; 63():152082. PubMed ID: 36634550
[TBL] [Abstract] [Full Text] [Related]
19. Effects of rosmarinic acid, carnosic acid, rosmanol, carnosol, and ursolic acid on the pathogenesis of respiratory diseases.
Farhadi F; Baradaran Rahimi V; Mohamadi N; Askari VR
Biofactors; 2023; 49(3):478-501. PubMed ID: 36564953
[TBL] [Abstract] [Full Text] [Related]
20. Structure-Based Discovery and Biological Assays of a Novel PRMT5 Inhibitor for Non-Small Cell lung cancer.
Chen Y; Zhang M; Wu A; Yao X; Wang Q
Molecules; 2022 Nov; 27(21):. PubMed ID: 36364261
[TBL] [Abstract] [Full Text] [Related]
[Next]
